Aoki
K, Barker C, Danthinne X, Imperiale MJ, Nabel GJ. Efficient generation
of recombinant adenoviral vectors by Crelox recombination in vitro.
Mol. Med. 5:224-231, 1999.
Anderson
RD, Haskell RE, Xia H, Roessler BJ, Davidson BL. A simple method
for the rapid generation of recombinant adenovirus vectors. Gene
Therapy 7(12):1034-1038, 2000.
Arosarena
OA, Baranwal S, Strome S, Wolf GT, Krauss JC, Bradford CR, Carey
TE. Expression of major histocompatibility complex antigens in
squamous cell carcinomas of the head neck: Effects of interferon
gene transfer. Otolaryngol Head Neck Surg 120:665-671, 1999.
Aruga,
A., Tanigawa, E., Aruga, E., Yu, H., Chang, A.E.: Enhanced adjuvant
effect of GM-CSF plus IL-12 compared to either alone in vaccine
induced tumor immunity. Cancer Gene Therapy, 6:89-95, 1999.
Chan,
S.Y., K. Li, J.R. Piccotti, M.C. Louie, T.A. Judge, L.A. Turka,
E.J. Eichwald and D.K. Bishop. Tissue specific consequences of
the anti-adenoviral immune response: Implications for cardiac
transplants. Nature Medicine 5:1143-1149, 1999.
Chang
AE, Li Q, Bishop DK, Normolle DP, Redman BD and Nickoloff BJ.
Immunogenetic therapy of human melanoma utilizing autologous tumor
cells transduced to secrete GM-CSF, Human Gene Therapy 11:839-850,
2000.
Hamstra
DA, Rice DJ, Fahmy S, Ross BD, Rehemtulla A. Enzyme/prodrug therapy
for head and neck cancer using a catalytically superior cytosine
deaminase. Human Gene Therapy 10:1993-2003, 1999.
Kievit
E, Bershad E, Ng E, Sethna P, Dev I, Lawrence TS, Rehemtulla A:
Superiority of yeast over bacterial cytosine deaminase for enzyme/prodrug
gene therapy in colon cancer xenografts. Cancer Research, 59:1417-21,
1999.
Tan,
J., Yang, N., Turner, J.G., Niu, G., Maassab, J.F., Sun, J., Herlocher,
M.L., Chang, A.E., Yu, H.: Interleukin-12 cDNA skin transfection
potentiates human papillomavirus E6 DNA vaccine-induced antitumor
immune response. Cancer Gene Therapy. 6:331-339, 1999.
Sanda
MG, Smith D, Charles LG, Hwang C, Pienta KJ, Schlom J, Milenic
D, Panicali D, Montie JE. Recombinant vaccinia-PSA can induce
a prostate-specific immune response in androgen-modulated human
prostate cancer. Urology, 53: 260-6, 1999.
Sisson
TH, Hattori N, Xu Y, Simon RH. Treatment of bleomycin-induced
pulmonary fibrosis by transfer of urokinase-type plasminogen activator
genes. Hum Gene Ther , 10:2315-2323, 1999.
Xie
YC, Hwan C, Overwijk W, Zeng, Z, Eng MH, Mulé JJ, Imperiale
MJ, Restifo NP, Sanda MG: Induction of tumor antigen-specific
immunity in vivo by a novel vaccinia vector encoding safety-modified
simian virus 40 T antigen. J NCI, 91:169-75, 1999.
